PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) Misses Q4 EPS by 14c, Revenues Beat

February 25, 2021 5:13 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($1.08), $0.14 worse than the analyst estimate of ($0.94). Revenue for the quarter came in at $118.86 million versus the consensus estimate of $111.36 million.

"Despite the challenges of the pandemic, PTC has been able to make significant... More